Form D · Pharmaceuticals

iPierian, Inc.

South San Francisco, CA · CIK 0001468247

Offering snapshot reported Nov 9, 2010 · SEC filing

Reported sold
$29M
Offering amount: $29M
Investors reported
20
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 1, 2010
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$14.5M$29MJul 15, 2010: $22,390,001.00Jul 15, 2010Sep 9, 2010: $28,470,000.00Sep 9, 2010Nov 9, 2010: $28,970,000.00Nov 9, 2010

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$28,470,000 → $28,970,000
  • Reported investors19 → 20

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 9, 2010Amendment$28,970,000$500,000vs Sep 9, 201020SEC filing
Sep 9, 2010Amendment$28,470,000$6,079,999vs Jul 15, 201019SEC filing
Jul 15, 2010Initial$22,390,001No comparison13SEC filing
Jul 16, 2009Initial$6,499,999No comparison4SEC filing
Jul 16, 2009Initial$938,590No comparison4SEC filing

Offering details

Securities
Equity, Other
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-144981
Series B Preferred Stock, including the shares of Common Stock issuable upon conversion of the Series B Preferred Stock.

Source: Form D, filed Nov 9, 2010. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Ashley Dombkowski Director
Corey Goodman Director
Robert F. Higgins Director
Bob Higgins Director
Jamie Kole Executive
Matthew J. Plunkett Executive
Beth Seidenberg Director
Berta Strulovici Executive
Michael Venuti Director, Executive
John Walker Director, Executive
Krishna Yeshwant Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
951 Gateway Boulevard
South San Francisco, CA, 94080